Skip to main content

Closed

QNCX: Quince Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-280.9%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio2.92×

Quince Therapeutics, Inc.

QNCXNASDAQ Global Select·USD·Closed

Quince Therapeutics, Inc.

QNCXNASDAQ·USD·Closed

$23.39

+1.56%

$23.39

+$0.36 (1.56%)

52W Range

1thpctl

Volume

0.63×avg

Mkt Cap

6.51MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.63×avg

Market Cap

6.51MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings